Bluejay Diagnostics Inc (BJDX)

$0.58

-0.03

(-4.45%)

Live

Performance

  • $0.57
    $0.59
    $0.58
    downward going graph

    1.38%

    Downside

    Day's Volatility :2.56%

    Upside

    1.19%

    downward going graph
  • $0.53
    $111.84
    $0.58
    downward going graph

    8.62%

    Downside

    52 Weeks Volatility :99.53%

    Upside

    99.48%

    downward going graph

Returns

PeriodBluejay Diagnostics IncIndex (Russel 2000)
3 Months
-87.13%
0.0%
6 Months
-92.48%
0.0%
1 Year
-98.58%
0.0%
3 Years
-99.93%
-19.2%

Highlights

Market Capitalization
3.6M
Book Value
$10.02
Earnings Per Share (EPS)
-60.64
Wall Street Target Price
256.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-78.77%
Return On Equity TTM
-155.5%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
48.9K
EBITDA
-9.5M
Diluted Eps TTM
-60.64
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.99
EPS Estimate Next Year
-0.32
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Sell
    0
    0%Buy
    50%Hold
    50%Sell
Based on 6 Wall street analysts offering stock ratings for Bluejay Diagnostics Inc(by analysts ranked 0 to 5 stars)
Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
3
3
3
Sell
3
3
3

Analyst Forecast

What analysts predicted

Upside of 44037.93%

Current $0.58
Target $256.00

Technicals Summary

Sell

Neutral

Buy

Bluejay Diagnostics Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bluejay Diagnostics Inc
Bluejay Diagnostics Inc
-81.29%
-92.48%
-98.58%
-99.93%
-99.93%
Stryker Corporation
Stryker Corporation
-1.55%
7.98%
13.65%
32.02%
65.15%
Boston Scientific Corp.
Boston Scientific Corp.
1.97%
28.95%
47.67%
84.27%
83.02%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
4.74%
22.98%
-1.79%
-14.43%
43.0%
Abbott Laboratories
Abbott Laboratories
0.74%
-8.39%
-2.6%
-10.66%
24.35%
Medtronic Plc
Medtronic Plc
-2.5%
-9.93%
-10.1%
-37.82%
-21.91%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bluejay Diagnostics Inc
Bluejay Diagnostics Inc
NA
NA
NA
-0.99
-1.55
-0.79
NA
10.02
Stryker Corporation
Stryker Corporation
38.74
38.74
2.92
11.95
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
64.8
64.8
1.8
2.33
0.09
0.05
NA
13.56
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
40.02
40.02
5.19
2.76
0.21
0.12
NA
11.82
Abbott Laboratories
Abbott Laboratories
32.2
32.2
5.99
4.63
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
27.92
27.92
1.52
5.2
0.07
0.04
0.04
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bluejay Diagnostics Inc
Bluejay Diagnostics Inc
Sell
$3.6M
-99.93%
NA
0.0%
Stryker Corporation
Stryker Corporation
Buy
$129.3B
65.15%
38.74
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$113.4B
83.02%
64.8
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$56.0B
43.0%
40.02
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$179.3B
24.35%
32.2
13.96%
Medtronic Plc
Medtronic Plc
Buy
$98.8B
-21.91%
27.92
11.36%

Insights on Bluejay Diagnostics Inc

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 46.5% return, outperforming this stock by 145.1%

Institutional Holdings

  • Sabby Management LLC

    6.45%
  • Armistice Capital, LLC

    6.06%
  • Renaissance Technologies Corp

    0.59%
  • Virtu Financial LLC

    0.37%
  • XTX Topco Ltd

    0.36%
  • Tower Research Capital LLC

    0.25%

Company Information

bluejay diagnostics, inc. is a medical diagnostics company focused on improving patient outcomes using its symphony system, a cost-effective, rapid, near-patient product for triage and monitoring of disease progression.

Organization
Bluejay Diagnostics Inc
Employees
10
CEO
Mr. Indranil Dey
Industry
Miscellaneous

FAQs